Intravenous Immunoglobulins Market to Reach US$ 15,789.1 Mn by 2025, Exhibiting A CAGR of 6.2% | Fortune Business Insights

    NEXT STORY
    ObsEva Hosts KOL Meeting on IVF Trends, Unmet Need and Market Potential of Nolasiban
    PREV STORY
    Point of Care/POC Diagnostics Market Worth $30.9 billion by 2024- Exclusive Report by Meticulous Research®
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Dimension Therapeutics Elects Dr. John A. Hohneker to Its Board of Directors

    CAMBRIDGE, Mass., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Dimension Therapeutics, Inc. (NASDAQ:DMTX), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    GeoVax and Leidos Enter into a Collaboration Agreement on Immunotherapy Research Program

    Combined Technologies May Yield Therapies for Multiple Cancer Indications  ATLANTA, GA, Nov. 19, 2018 ...

    author_avatar
    NASDAQ Market News

    ContraFect Corporation Prices $10 Million Public Offering of Common Stock

    YONKERS, N.Y., July 27, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a biotechnology company ...

    author_avatar
    NASDAQ Market News